Growing evidence indicated that LOX promotes tumor formation and progression, such as glioblastoma multiforme, hepatocellular carcinoma, etc. [40–43]; in these studies, the overexpression of LOX is associated with tumor malignancy and poor prognosis. The gene discussed is LOX; the disease is hepatocellular carcinoma.